60 related articles for article (PubMed ID: 7531410)
21. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
22. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
Wang Y; Georges E
Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
[TBL] [Abstract][Full Text] [Related]
23. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
24. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
Li Y; Wang Y
Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322
[TBL] [Abstract][Full Text] [Related]
25. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
Arora A; Seth K; Kalra N; Shukla Y
Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
[TBL] [Abstract][Full Text] [Related]
26. Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line.
Le Moyec L; Tatoud R; Degeorges A; Calabresse C; Bauza G; Eugène M; Calvo F
Cancer Res; 1996 Aug; 56(15):3461-7. PubMed ID: 8758912
[TBL] [Abstract][Full Text] [Related]
27. Emetine resistant mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance.
Samuelson J; Ayala P; Orozco E; Whirth D
Arch Invest Med (Mex); 1990; 21 Suppl 1():183-9. PubMed ID: 1983787
[TBL] [Abstract][Full Text] [Related]
28. Isolation and expression of a complementary DNA that confers multidrug resistance.
Gros P; Ben Neriah YB; Croop JM; Housman DE
Nature; 1986 Oct 23-29; 323(6090):728-31. PubMed ID: 3022150
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of putative intrinsic multidrug resistant Chinese hamster ovary cells by fluorescence activated cell sorting.
Zou CP; Van NT; Kuo MT
Anticancer Res; 1992; 12(2):427-32. PubMed ID: 1349795
[TBL] [Abstract][Full Text] [Related]
30. Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug resistant phenotype.
Croop JM; Guild BC; Gros P; Housman DE
Cancer Res; 1987 Nov; 47(22):5982-8. PubMed ID: 3664502
[TBL] [Abstract][Full Text] [Related]
31. Detection of cells with multidrug-resistant phenotype in myeloproliferative disorders before therapy.
Kemnitz J; Freund M; Dominis M; Cohnert TR; Uysal A; Georgii A
Hematol Pathol; 1989; 3(2):73-8. PubMed ID: 2570776
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.
Solary E; Ling YH; Perez-Soler R; Priebe W; Pommier Y
Int J Cancer; 1994 Jul; 58(1):85-94. PubMed ID: 8014019
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.
Borrel MN; Fiallo M; Priebe W; Garnier-Suillerot A
FEBS Lett; 1994 Dec; 356(2-3):287-99. PubMed ID: 7805856
[TBL] [Abstract][Full Text] [Related]
34. Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.
Priebe W; Van NT; Burke TG; Perez-Soler R
Anticancer Drugs; 1993 Feb; 4(1):37-48. PubMed ID: 8457713
[TBL] [Abstract][Full Text] [Related]
35. Characterization of an anthracycline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated MDR-1 gene expression.
Jönsson K; Dahlberg N; Tidefelt U; Paul C; Andersson G
Biochem Pharmacol; 1995 Mar; 49(6):755-62. PubMed ID: 7702633
[TBL] [Abstract][Full Text] [Related]
36. Differential reversal of lipophilic antifolate resistance in mammalian cells with modulators of the multidrug resistance phenotype.
Assaraf YG; Borgnia MJ
Anticancer Drugs; 1993 Jun; 4(3):395-406. PubMed ID: 8102912
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of a Chinese hamster ovary cell mutant with improved staining for indo-1.
Wieder ED; Fox MH
Cytometry; 1994 Sep; 17(1):33-8. PubMed ID: 7528122
[TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein (P-gp) in the monogonont rotifer, Brachionus koreanus: molecular characterization and expression in response to pharmaceuticals.
Rhee JS; Jeong CB; Kim BM; Lee JS
Aquat Toxicol; 2012 Jun; 114-115():104-18. PubMed ID: 22446822
[TBL] [Abstract][Full Text] [Related]
39. Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.
Conforti G; Codegoni AM; Scanziani E; Dolfini E; Dasdia T; Calza M; Caniatti M; Broggini M
Br J Cancer; 1995 Mar; 71(3):505-11. PubMed ID: 7880731
[TBL] [Abstract][Full Text] [Related]
40. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
Hoffman MM; Wei LY; Roepe PD
J Gen Physiol; 1996 Oct; 108(4):295-313. PubMed ID: 8894978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
